Francis Knuettel II
Chief Accounting Officer
Pelthos Therapeutics Inc. (PTHS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francis Knuettel II
Francis Knuettel II is recorded as Chief Accounting Officer, CFO and CEO at Pelthos Therapeutics Inc. (PTHS). Pelthos Therapeutics Inc. reported in an 8-K filed May 21, 2026 that Francis Knuettel II was terminated as Chief Financial Officer, Treasurer and Secretary, effective April 10, 2026. Pelthos Therapeutics Inc. reported in an 8-K filed April 10, 2026 that Francis Knuettel II was terminated as Chief Financial Officer, effective April 10, 2026. Pelthos Therapeutics Inc. reported in an 8-K filed July 2, 2025 that Francis Knuettel II was appointed principal accounting officer, effective July 1, 2025. Equibles holds 6 filed executive changes naming Francis Knuettel II; each is listed under recent activity with its source filing. The proxy statement of Pelthos Therapeutics Inc. reports total compensation of $2,288,234 for Francis Knuettel II in fiscal 2025, including a base salary of $410,000. Disclosed compensation is on record for 3 fiscal years.
“the Board terminated Francis Knuettel II from his position as Chief Financial Officer, Treasurer and Secretary of the Company, effective April 10, 2026.”
“Also on April 6, 2026, prior to the Board’s election of Mr. Gay as Chief Financial Officer, the Board terminated Francis Knuettel II from his position as Chief Financial Officer of the Company, effective April 10, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-07-01–present
-
Current
2025-07-01–present
-
Pelthos Therapeutics Inc. (PTHS)
SEC 8-K
Current2024-11-18–present
-
Current
2024-03-13–present
-
2024-03-13–2025-07-01
-
2024-01-01–2025-07-01
-
Start not stated–2026-04-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pelthos Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Christian Kopfli CEO
- Scott Plesha CEO, Board Member
- Frank Knuettel CFO
- Frank Knuettel II CFO
- John M. Gay CFO
- Andrew Einhorn Board Member
- Andrew J. Einhorn Board Member
- Dr. Richard Malamut Board Member
- Ezra Friedberg Board Member
- Francis Knuettel Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pelthos Therapeutics Inc. (PTHS) | Former Chief Financial Officer; Former Chief Executive Officer | $410,000 | $2,288,234 |
| 2024 | Pelthos Therapeutics Inc. (PTHS) | Former Chief Financial Officer; Former Chief Executive Officer | $424,923 | $1,205,255 |
| 2023 | Pelthos Therapeutics Inc. (PTHS) | Chief Executive Officer and Chief Financial Officer | $107,500 | $307,010 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.